CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors

Positive
AI Analysis

Summary

BioMarin announced the appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to its Board of Directors.

Importance:2/10
Sentiment:
0.30
board_appointmentmanagementcorporate_governance
Related Companies

Read the original article

Published by yahoo_finance on September 14, 2026 1:05 PM

Read Original